SPE Plates
Med Vet International 30mg Vetoryl (Trilostane) Capsules, 30ct
VET LICENSE NEEDS TO BE PROVIDED IN 3-4 BUSINESS DAYS OR ORDER WILL BE CANCELLED
THIS PRODUCT IS NOT RETURNABLE. Vetoryl Capsules contain an adrenosuppressant drug that is used to treat hyperadrenocorticism in dogs. Hyperadrenocorticism (also known as Cushing's disease) is a condition in which excess levels of the hormone cortisol are produced. This product is for oral use in dogs only
Biotage PPT+ PLATE 2 ML 1
Well, Fixed plate; Biotage; Isolute; SPE; 96-well; For protein precipitaion; Capacity: 2mL; 1/pk.
Phenomenex Inc 96-Well Plate, 10mg/well
Strata™-X-Drug B Plus 33m Polymeric Strong Cation 8E-S128-AGB-P
Perkin Elmer US LLC S20 Series Organics Consumables Kit
The contents of this kit are described as follows: (1) Filtered Stainless Steel Probe (N0771529) (1) Probe Fitting Kit (N0830022) (1) Metal Rack, 60 Locations (N0811959)* (1) Tygon Rinse and Waste Peripump Tubing - Yellow (N0831036) (1) Peripump Tubing Viton Kit (N0831040) (1) Dual Rinse Station (N0831032) (2) Narrow Neck Bottles without Covers, 2000 mL (B0104344) *Only one sample rack is shipped with the Organics kit. Any additional racks required will need to be ordered separately.
Cayman Chemical SPE CartrIdgesMIxed Bed 5ea
Mixed-mode cartridges packed with non-polar and strong anion exchange chemistries
Waters Corp Oasis Peptide Method Development 96-well µElution Plate, 2 mg Sorbent per Well, 30 µm, 1/pk
Oasis Peptide Method Development µElution Plate is designed to simplify the process of sample preparation for the analysis of therapeutic peptides in plasma. The 96-well plate format contains six rows each of two Oasis mixed-mode, ion-exchange chemistries: a strong exchanger (MAX) and a weak cation exchanger (WCX). Sample preparation method development can be quickly and easily achieved with the use of a single SPE protocol. The Oasis Peptide µElution Method Development Plate is sold separately or as a component of the UPLC Therapeutic Peptide Method Development Kit (176001835) and the HPLC Therapeutic Peptide Method Development Kit (176001836).